hypothesis of the viral aetiology of schizophrenia has been supported mainly by indirect epidemiological evidence. Both serological studies looking for anti viral antibodies, and attempts to identify virus material in CSF and post-mortem brain, have led to inconsistent results. Research on anti-viral antibodies in the serum and CSF of schizophrenic patients have shown higher titres against cytomegalovirus (CMV), herpes simplex virus (HSV), influenza, and measles than in controls (Halonen et a!, 1974; Albrecht eta!, 1980; Torrey eta!, 1982; Libikova, 1983) , but these results have not been reproduced by others (Lycke et a!, 1974; Gotlieb-Stematsky et a!, 1981; King et a!, 1985; DeLisi et a!, 1986) . Seasonality of birth in schizophrenia has been supported by numerous epidemiological studies that showed an excess of late winter-spring births of schizophrenics (Torrey, 1988) ; however, the seasonal effect is still controversial (Lewis, 1989) . Since some viruses have an increased incidence during the winter it was suggested that viral infection may explain seasonality. Schizophrenia-like psychoses have been reported as sequelae of encephalitis lethargica, influenza and herpes simplex encephalitis and undiagnosed virus like illnesses (Torrey, 1988; Stevens & Hallick, 1992) , suggesting that viruses may be associated with schizophrenia. Attempts to detect viral antigens using immuno cytochemical methods (Stevens et a!, 1983 (Stevens et a!, , 1984 ; The recently developed polymerisation chain reaction (PCR) for the amplification of nucleic acids is the most sensitive assay for the detection of viral agents (Innis et a!, 1990) . PCR produces a million-fold amplification of the nucleic acid viral sequences, and has been used to search for CMV, herpes simplex virus, and varicella-zoster virus in the temporal cortex of the post-mortem brains of schizophrenic patients (Alexander et a!, 1992a,b) , with negative results. A reverse transcription PCR for BDV was unable to detect the virus in the post-mortem brain tissue of 16 schizophrenic patients (Shankar et a!, 1992) . We used PCR to examine the CSF and brain tissue (hippocampus) of schizophrenic patients, CSF and PBMC of identical twins discordant for schizophrenia, and SK-N-SHEP (human neuroblastoma) cells et al, 1988) . Recently, serological evidence of BDV infection has been found in humans with psychoses, affective disorders, and chronic progressive diseases of the brain and immune system (Amsterdam et a!, 1985; Rott eta!, 1985; Bode eta!, 1988 Bode eta!, , 1992 (Chomczynski & Sacchi, 1986) .
All procedures for sample preparation, DNA and RNA extraction, and PCR amplification included strict measures to avoid cross-contamination between sample and contamination of reagents or samples with PCR products. The samples were processed with disposable materials in an area that was not used for any other procedures related to PCR. Gloves were changed between each sample. In each group of extractions, reverse transcriptions and PCR, we included several negative controls: two cocktail controls without sample and parallel reaction mixtures without reverse transcriptase for each sample tested.
Reverse transcription
The reverse transcription was performed as previously described (Sierra-Honigmann eta!, 1993) The RNase-inhibitor and the Moloney murine leukaemia virus (MMLV) reverse transcriptase were obtained from Boehringer Mannheim, Indianapolis, IN, USA, the random primers and deoxynucleotides were from Pharmacia, LKB, Piscataway, NJ, USA. As controls, aliquots of each RNA sample were incubated with the reaction mixture lacking the enzyme reverse transcriptase. The RNA extracted from the hippocampus of schizophrenic patients and non-schizophrenic controls was reverse-transcribed and amplified with the primers for the human glyceraldehyde-3-phosphate-dehydrogenase mRNA to control for RNA degradation and the reverse transcription reaction.
Polymerase chain reaction

Methods
All patients met DSMâ€"IIIâ€"R criteria (American Psychiatric Association, 1987) for the diagnosis of schizophrenia. The left hippocampus of six post mortem brains from three schizophrenic subjects and three non-schizophrenic controls matched for age and gender were tested in this study. The brain tissue was obtained between 12 and 24 h after death. The brain tissue was frozen and stored at â€"¿ 70Â°C.Of these schizophrenic subjects, two were males (42 and 49 years old) and one female (35 years old). We tested 48 samples of CSF from schizophrenic patients and nine sets of CSF and peripheral blood mononuclear cells (PBMC) from monozygotic twins discordant for schizophrenia. Seven of the nine sets of discordant twins were male and two were female. CSF and blood samples were obtained with informed consent of the subjects. Schizophrenic patients (but not the controls) were receiving neuroleptics at the time of collection of samples.
Cell culture
We used the SK-N-SHEP cell line, derived from a human neuroblastoma tumour. Pools of the post mortem brain hippocampus were homogemsed with 4 volumes (1:5 w/v) of minimum essential media (MEM) containing 2% foetal bovine serum. The homogenate was sonicated, filter-sterilised, and added to the SK-N-SHEP cells in a 1:100 final dilution. The cell cultures were passaged five times in MEM with 10Â°lo of foetal bovine serum, the cells Amplifications were performed in a 100 @l volume as previously described (Sierra-Honigmann et a!, 1993). Amplitaq was obtained from Cetus-Perkin Elmer, Emeryville, CA, USA. Samples were overlaid with 100 1dof mineral oil and amplified through 30
cycles of denaturation at 94Â°Cfor 1 mm, annealing at 55Â°Cfor I mm, and DNA synthesis at 72Â°Cfor 1 mm using the Perkin-Elmer thermal cycler. PCR for CMV was done as previously described (McClure eta!, 1992) .The sequences of the primers used for the Al/Ann Arbor/l/57 and the CMV AD-l69 strains were obtained from the ATCC (American Type Culture Collection, Rockville, MD, USA). Inner sets of primers containing a T7 promoter were used to synthesise nested biotinylated RNA probes to detect the PCR products with an enzyme immunoassay (EIA).
Preparation of RNA probes
The biotinylated RNA probes were prepared as previously described (Sierra-Honigmann eta!, 1993) . The viral sequences were amplified with the inner set of primers, and the PCR products were used as templates in a standard transcription reaction with T7 RNA polymerase in the presence of biotinylated UTP (bio-ll-UTP, Enzo Diagnostics Inc, New York, 
Detection of amplified DNA by enzyme immunoassay
The non-isotopic solution hybridisation assay was performed as described previously (Coutlee et a!, 1990). Briefly, the PCR products were hybridised with the biotinylated RNA probe for 60 mm at 78Â°C. Aliquots were tested in triplicate wells of a black microtitre plate (microfluor â€˜¿ B' 96 U-microfluor microtitre plate fluorometer, detection wavelength 365 nm, emission wavelength 450 nm). A sample was considered positive if the mean fluorescent value was more than three standard deviations (s.d.) above the control. 
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Detection of amplified DNA by gel electrophoresis
The PCR products were analysed by polyacrylamide gel electrophoresis (PAGE). Samples were loaded in a 7.5Â°lo polyacrylamide slab gel and silver stained as previously described (Herring et a!, 1982) .
Results
To look for viral nucleic acid sequences, we used PCR assays which included positive control samples. and the BDV RT-PCR-EIA was found to be capable of detecting BDV sequences in 0.001 BDV-infected C6 cells (Sierra-Honigmann eta!, 1993) . In addition, the relative sensitivity of the CMV and Influenza A assays suggest that sensitivity was not a limiting factor in this study. The primers specific for CMV, HIV, and Influenza virus have been used to detect several strains and isolates of these known human pathogens (Demmier eta!, 1988; Coutlee et a!, 1990 ) and were designed to amplify viral sequences that show little variability. BDV and BVDV are animal pathogens that have not been conclusively shown to infect humans, in spite of the fact that several studies have shown immunoreactivity to BDV in the serum of patients with psychiatric disorders. Serological studies have shown immunoreactivity to BVDV in the sera of some schizophrenic twins discordant for schizophrenia (Yolken et a!, 1992); however, we were not able to detect BVDV-specific nucleic acid sequences in any of the samples tested here. The discrepancy between finding antibodies to BDV and BVDV and being unable to amplify the viral genome could be explained by the possibility that the BDV and BVDV primer sequences that we used may correspond to regions of the viral genome that are not evolutionarily conserved in a related virus that could infect humans. Additional studies should be for schizophrenia, or SK-N-SHEP cells co-cultured with schizophrenic brain and non-schizophrenic brain homogenates. The same samples were also negative when amplified with the Influenza A primers as determined by polyacrylamide gel electrophoresms(data not shown). The human glyceraldehyde-3-phosphate dehydrogenase mRNA used as a control was positive in all six hippocampus samples (data not shown), indicating that the RNA extraction procedure and the reverse transcription reaction produced material that was capable of being amplified by PCR.
Discussion
PCR amplification is the most sensitive method for
detecting specific viral nucleic acids. The PCR-EIA directed at the detection of strains of these viruses that might be capable of human infection.
The inability to detect CMV in the hippocampus of the post-mortem brains of schizophrenic patients in this study is in agreement with a previous report that showed no evidence of CMV in the temporal cortex using PCR (Alexander et a!, 1992a ).
Since schizophrenia can be associated with structural and physiological pathology of the limbic system and the temporal lobe (Stevens et a!, 1992) , the hippocampus of the post-mortem brain of schizophrenic subjects was tested in this study. Disarray of the hippocampal pyramidal cells (Scheibel & Kovelman, 1981) and a reduced size of the hippocampal region have been reported in the schizophrenic twin of monozygotic pairs discordant for schizophrenia (Suddath eta!, 1990) .Nevertheless, our negative results could mean that the viral agent was located in a different brain region. In addition, it is possible that a viral infection during embryo genesis may interfere with normal development even if the infection does not persist.
With the exception of Influenza A and BVDV the viruses tested in this study (HIV, CMV, and BDV) can infect cells of the nervous and the immune system (Schrier & Oldstone, 1986; McChesney & Oldstone, 1987; Moennig & Plagemann, 1992; Sierra-Honigmann et a!, 1993) . It is possible that a virus associated with schizophrenia could be infecting the brain and the immune system of schizophrenic patients. The presence of such a virus in cells of the immune system would not necessarily mean that it is related to the aetiology of schizophrenia, but it would make this tissue a good place to search for viral nucleic acid sequences. Therefore, we tested PBMC of monzygotic twins discordant for schizophrenia. The lack of evidence of viral infection in these samples should not discourage including PBMC in future studies, since PBMC is an easily obtainable tissue and there are numerous viruses that infect the nervous and immune systems, such as measles (Ahmed & Stevens, 1990) , Epstein-Barr virus (EBV) (Grose et a!, 1973) and those mentioned above. The failure to detect viral nucleic acid sequences in this study suggests that schizophrenia is not associated with an ongoing persistent or latent infection due to these viruses. However, it should be noted that these results do not rule out the possible role of viral infections in schizophrenia. It is possible, for example, that viral infections which occurred earlier in life resulted in disease in the absence of persistent infection in the sites that were sampled. A viral infection could have triggered an auto-immune response without a current presence of the virus in the brain tissue. It is also possible that schizophrenia could be associated with other viral agents, including ones which have not yet been recognised as human pathogens. Additional studies should be directed at the use of molecular and cellular techniques for the detection of such agents and for the determination of their role in human neuropsychiatric diseases.
